<p>Understanding how the first cell lineages in human development are specified and maintained has fundamental importance and clinical implications for regenerative medicine, infertility and pregnancy loss. While mouse models have provided valuable insights into transcription factors regulating early development, translating these findings to human embryos has been limited by ethical, technical and biological constraints. Functional studies of transcription factors in human embryos have been hindered by nuclease-based genome-editing approaches that induce genotoxicity<sup>1-3</sup>. To overcome this, we applied adenine base editing (ABE8e)<sup>4,5</sup> to precisely target an exon splice donor site, resulting in a splicing defect and functional knockout of NANOG, representing the first application of base editing to study a developmental regulator in human embryos. This approach did not trigger genotoxicity and showed limited off-target editing. Loss of&#xa0;<i>NANOG</i>&#xa0;disrupts pluripotent epiblast specification and instead cells differentiate toward a primitive endoderm (yolk sac) or trophectoderm (placental) transcriptional programme. Retention of primitive endoderm differentiation in <i>NANOG</i>-edited human embryos reveals a functional compensation distinct from mouse, underscoring the importance of directly investigating human development. Our findings demonstrate an essential role for NANOG in human pluripotency and epiblast specification, and highlight the utility of base editing for functional interrogation of human development.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Base editing reveals an essential role for NANOG in human embryogenesis

  • Oliver J. Bower,
  • Ana E. R. Orsi,
  • Riley McMahon,
  • Desislava Staneva,
  • Josephine Blagrove,
  • Kashish Singh,
  • Claire S. Simon,
  • Afshan McCarthy,
  • Patricia Garcia,
  • Valerie Shaikly,
  • Mohamed Taranissi,
  • Martin Wilding,
  • Paul Serhal,
  • Rabi A. Odia,
  • Mina Vasilic,
  • Meenakshi Choudhary,
  • Athanasios Papathanasiou,
  • Kay Elder,
  • Phil Snell,
  • Leila Christie,
  • Mandana Arbab,
  • David R. Liu,
  • Mary Herbert,
  • Katarina Harasimov,
  • Kathy K. Niakan

摘要

Understanding how the first cell lineages in human development are specified and maintained has fundamental importance and clinical implications for regenerative medicine, infertility and pregnancy loss. While mouse models have provided valuable insights into transcription factors regulating early development, translating these findings to human embryos has been limited by ethical, technical and biological constraints. Functional studies of transcription factors in human embryos have been hindered by nuclease-based genome-editing approaches that induce genotoxicity1-3. To overcome this, we applied adenine base editing (ABE8e)4,5 to precisely target an exon splice donor site, resulting in a splicing defect and functional knockout of NANOG, representing the first application of base editing to study a developmental regulator in human embryos. This approach did not trigger genotoxicity and showed limited off-target editing. Loss of NANOG disrupts pluripotent epiblast specification and instead cells differentiate toward a primitive endoderm (yolk sac) or trophectoderm (placental) transcriptional programme. Retention of primitive endoderm differentiation in NANOG-edited human embryos reveals a functional compensation distinct from mouse, underscoring the importance of directly investigating human development. Our findings demonstrate an essential role for NANOG in human pluripotency and epiblast specification, and highlight the utility of base editing for functional interrogation of human development.